400-82-02
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| g | ￥ ţǐĕƘƘ | > 0 | > 0 | -- | 3 | 4 | 2 | ￥ ţǐĕƘƘ | - + |
| 0g | ￥ żżĕƘƘ | > 0 | > 0 | -- | 2 | 2 | ￥ żżĕƘƘ | - + | |
| 2g | ￥ ŊĿţĕƘƘ | 8 | > 0 | -- | 3 | 4 | 2 | ￥ ŊĿţĕƘƘ | - + |
| 00g | ￥ ĨĠƍĕƘƘ | 2 | 3 | -- | 2 | 3 | ￥ ĨĠƍĕƘƘ | - + | |
| 00g | ￥ ƍĨĿƍĕƘƘ | -- | -- | -- | -- | -- | -- | ￥ ƍĨĿƍĕƘƘ | - + |
| 000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
8.6
[]. A Louie, et al. Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. Antimicrob Agents Chemother. 998 May;42():0-9.
[2]. H Yamaguchi, et al. [In vitro activity of fluconazole, a novel bistriazole antifungal agent]. Jpn J Antibiot. 989 Jan;42():-6.
[3]. M A Pfaller, et al. Interpretive breakpoints for fluconazole and <i>Candida</i> revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev. 2006 Apr;9(2):43-4.
[4]. P G Sohnle, et al. Effect of fluconazole on viability of Candida albicans over extended periods of time. Antimicrob Agents Chemother. 996 Nov;40():2622-.
[]. Christopher C Blyth, et al. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. J Paediatr Child Health. 202 Sep;48(9):846-.
H302-H360-H42
P264-P20-P23-P280-P330-P40-P0
GHS0,GHS08
293 货期咨询
3094 货期咨询
300 货期咨询
9849 货期咨询
3094 货期咨询
3096 货期咨询
30924 货期咨询
3089 货期咨询
20466 货期咨询
￥ ȕĿżǐĕƘƘ -g
30933 货期咨询
￥ ȕĨţĕƘƘ -0mg
沪ICP备0964号
